Highlights Quarter one revenue of $2,034.0 million, an increase of 0.9% on quarter one 2025. Quarter one adjusted EBITDA of $317.7 million or 15.6%...
Barchart Research What to Expect from ICLR Earnings ICLR Generated June 22, 2026 Current Price $140.73 EPS Estimate $$2.18 Consensus Rating Moderate Buy Average Move 10.64% ICON's Backlog Momentum Could...
ICON plc (NASDAQ: ICLR) today announced that it has selected Microsoft as a preferred technology partner – further advancing ICON’s previously announced plan to invest in digital innovation...
ICON plc , (NASDAQ: ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the first quarter 2026 after the market closes...
Barchart Research What to Expect from ICLR Earnings ICLR Generated June 16, 2026 Current Price $143.54 EPS Estimate $$2.18 Consensus Rating Moderate Buy Average Move 10.64% ICON's Earnings Land One Day...
Barchart Research What to Expect from ICLR Earnings ICLR Generated June 9, 2026 Current Price $151.82 EPS Estimate $$2.18 Consensus Rating Moderate Buy Average Move 10.64% Icon's Guidance Reset Meets First...
Barchart Research What to Expect from ICLR Earnings ICLR Generated June 2, 2026 Current Price $137.54 EPS Estimate $$2.73 Consensus Rating Moderate Buy Average Move 10.64% ICON's Clinical Trial Backlog...
Icon (NASDAQ:ICLR) executives used the company’s latest earnings call to address the results of an accounting investigation, outline fourth-quarter and full-year 2025 performance, and provide guidance...